About This Event

Hemab Therapeutics (Nasdaq: COAG), a clinical-stage biotechnology company developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience visits the Nasdaq MarketSite in Times Square.

In honor of the occasion, Benny Sorensen, MD, PhD, Chief Executive Officer and Mads Behrndt, MSc, Chief Financial Officer and General Manager ring the Opening Bell.